Furthermore, PI3K/Akt/mTOR inhibition induced apoptosis in primary AML cells and potentiated response to cytotoxic chemotherapy, while sparing normal HSC function, [23,24,25,26]. This evidence concerns the gene PIK3CD and acute myeloid leukemia.